RES Group Industries : Pharmaceutical

RES Group helps pharmaceutical & biotechnology companies achieve successful results in the rapidly changing world of life sciences. We collaborate with leading companies to identify novel pharmaceutical drug targets, develop lead compounds for a variety of diseases, utilize patient data to streamline clinical trial design, and assist in drug manufacturing sciences. Our team is experienced in a wide range of projects. Through cutting-edge technologies & skills, we help our clients develop successful drugs to treat diseases such as cancer, cardiovascular, diabetes, hepatitis C and Alzheimer's.

Project Highlights

Scope

Identify New Drug Targets
Treatment Strategies
Validate New Methodologies
Mechanism-of-action

Drug Design Improvement
Next-Gen Drug Design
Experimental Design
Drug-Failure Analysis
PBPK Models

Optimal Dose
Dose Schedule
Predict Effect Size
Inclusion/Exclusion Critera
Biomarkers of Response

Routes of Synthesis
Crystallization
Morphology Control
Scale-Up
Process Optimization

Drug Discovery &
Development

RES has deep expertise in the fields of drug discovery and development, helping our pharmaceutical partners bring new and innovative drugs to market.

Scope of Expertise:
» Possible Causes
» Mechanism of Action
» Disease Progression
» Treatment Possibilities
» Novel Drug Target Identification
» Drug Failure Analysis
» Next-Gen Drug Design

Disease Area Expertise:
» Cancer (Multiple Subtypes)
» Autoimmunity
» Parkinson's Disease
» Alzheimer's Disease
» Cardiovascular Disease
» Chronic Pain
» Osteoporosis & Bone
» Remodeling
» Lipoprotein Metabolism
» Signal Transduction

Clinical Trials

Often the most important and costly step in the pharmaceutical developmental cycle, RES scientists can help extract insight from often-underutilized clinical trial data. These insights are then leveraged toward better design of subsequent clinical trials and in some cases, better next generation drug design.

Clinical Trial Expertise:
» Drug Design/Revision
» Drug Administration
» Drug Distribution
» Effectiveness
» Safety
» Optimal Dose
» Trial Duration
» Inclusion/Exclusion Criteria
» Biomarkers of Response
» Expected Effect Size
» New PKPD Algorithm Development
» PBPK Models of Drug Distribution

Solutions, Delivered.

RES has delivered successful solutions to customers around the world. Over 90% of RES' customers are repeat customers with expanding relationship.